At IMMUNOLOGY2026™, AAI will recognize the six ASPIRE awardees for this year at the Business Meeting on Friday, April 17, at 10:15 AM. This award encourages and fosters the development of talented early-career AAI member scientists to continue advancing their research activities and scientific contributions in the field of immunology.
The 2026 ASPIRE awardees will present lectures at special symposia on April 16, 17, and 18. They will be joined by two of last year’s awardees who were unable to attend the annual meeting in 2025. View the slideshow below to learn more about the new awardees and their presentations:
David A. Braun, MD, PhD, will present his lecture, “Determinants and augmentation of effective anti-tumor immunity in kidney cancer.” at the AAI ASPIRE Awards Symposium, Saturday, April 18, at 8:00 AM.
Camila H. Coelho will present her lecture, “Discovery and targeting of human B cell epitopes to counter emerging threats,” at the AAI ASPIRE Awards Symposium, Friday, April 17, at 8:00 AM.
Alex Gitlin, MD, PhD, will present his lecture, “Insights into VEXAS syndrome: How the cell death machinery unleashes inflammation,” at the AAI ASPIRE Awards Symposium, Saturday, April 18, at 8:00 AM.
Tobias Lanz, MD, will present his lecture, “The link between Epstein-Barr virus and multiple sclerosis – molecular mimicry and beyond,” at the AAI ASPIRE Awards Symposium, Thursday, April 16, at 8:00 AM.
Sadiya Parveen-Nesson, PhD, will present her lecture, “Harnessing the ghosts of influenza past to generate protective humoral immunity” at the AAI ASPIRE Awards Symposium, Friday, April 17, at 8:00 AM.
Michael Wheeler, PhD, will present his lecture, “Peripheral immune signatures that orchestrate complex behavior,” at the AAI ASPIRE Awards Symposium, Thursday, April 16, at 8:00 AM.
From the class of 2025 ASPIRE Awardees, Anna-Maria Globig, MD, will present her lecture, “Sympathetic nerves regulate T cell differentiation in viral infection and cancer on Thursday, April 16, and Brandon J. DeKosky, PhD, will present his lecture, “Scalable platforms to study and engineer immune receptors,” on Friday, April 17.